Press Releases


Mass General team identifies DNA element that may cause a rare movement disorder

A team of Massachusetts General Hospital researchers has identified a specific genetic change that may be the cause of a rare but severe neurological disorder called X-linked dystonia parkinsonism, which occurs only among individuals with ancestry from the Philippines island of Panay.

Patient satisfaction, communication with caregivers can reduce risk of hospital readmission

A survey of patients admitted to Massachusetts General Hospital has found that patients reporting greater levels of satisfaction with their care and good communication with their health care providers were significantly less like to readmitted to the hospital in the 30 days after discharge.

Novel harvesting method rapidly produces superior stem cells for transplantation

A new method of harvesting stem cells for bone marrow transplantation – developed by a team of investigators from the Massachusetts General Hospital Cancer Center and the Harvard Stem Cell Institute – appears to accomplish two goals: making the donation process more convenient and less unpleasant for donors and providing cells that are superior to those acquired by current protocols.

When the doctor is away

A new method of harvesting stem cells for bone marrow transplantation – developed by a team of investigators from the Massachusetts General Hospital Cancer Center and the Harvard Stem Cell Institute – appears to accomplish two goals: making the donation process more convenient and less unpleasant for donors and providing cells that are superior to those acquired by current protocols.

Targeting the bone marrow to drive brain repair after radiation injury

Researchers leverage a link between the bone marrow and brain regeneration, aiming to improve outcomes for brain tumor patients with radiation injury.

Opioid deaths jump

People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by a Harvard Medical School/Massachusetts General Hospital investigator.

Study finds more than 1 in 56 patients who undergo revascularization readmitted within 30 days

A study of nearly 62,000 hospitalizations nationwide has found that more than one in six patients with peripheral arterial disease who undergo revascularization procedures to restore blood flow to blocked leg arteries and other arteries outside of the heart are readmitted to the hospital within 30 days.

In Depth

Brain imaging studies provide new insights into biological basis of behaviors in schizophrenia and autism

Martinos Center researchers Nouchine Hadjikhani, MD, PhD and Daphne Holt, MD, PhD, are using brain imaging technology to learn more about how individuals with autism and schizophrenia view the world through different lenses.

Breton details the benefits of serving as an elected ECOR representative

As an elected ECOR representative, Sylvie Breton, PhD, has advocated for new programs and initiatives to support researchers at Massachusetts General Hospital. She has also made connections across the institution that have aided the research efforts in her lab.

Infectious disease researchers worried about effect of cuts to NIH's Fogarty Center

Researchers in the Division of Infectious Disease at Massachusetts General Hospital say that the elimination of funding to the Fogarty International Center could result in significant setbacks to infectious disease research and treatment worldwide.

Shining a light on MS-related fatigue

Farrah J. Mateen, MD, PhD, Director of the MGH Multiple Sclerosis Clinic at Massachusetts General Hospital, is investigating whether light therapy could improve symptoms of fatigue in patients with multiple sclerosis.

Team effort helps find first answers to complex genetic basis of Tourette syndrome

A large scale analysis of genetic information from individuals with Tourette syndrome led by researchers at Massachusetts General Hospital and UCLA has identified alterations in two genes that significantly increase the risk of developing the disorder.

Site-specific chemotherapy treatment could bring new hope to pancreatic cancer patients

A team of researchers from the Massachusetts General Hospital and MIT have developed an innovative new strategy for treating pancreatic cancer with an implantable mesh patch designed to deliver chemotherapy drugs directly to the cancer site.

See more stories

Investigator Profiles

Gatchel works to untangle the connections between mental health issues and cognitive decline in aging adults

Massachusetts General Hospital researcher Jennifer Gatchel, MD, PhD, is using brain imaging technology to learn more about the connections between mental illness and cognitive decline in aging populations.

Maguire hopes to improve gene therapy treatments by hiding viruses from the immune system

Massachusetts General Hospital researcher Casey Maguire, PhD, is developing new strategies to shield virus-based gene therapy treatments from the immune system to help patients with genetic disorders.

Eddy's research offers hope for long-term recovery from eating disorders

Kamryn Eddy, PhD, is part of a research team that recently published the results of a long-term study analyzing the recovery rates of patients with eating disorders. What the team found provides new reasons for hope for individuals with bulimia and anorexia.

Uygun is putting the pieces together in quest to create new livers in the lab

Basak Uygun, PhD, a researcher at the Center of Engineering in Medicine at Massachusetts General Hospital, is working on ways to create bioengineered livers in the lab that could one day be used in patients with liver failure.

Meet the researcher who wants to diagnose respiratory illness with a Smartphone

Peter Moschovis, MD, MPH, is helping to develop new digital technology that could provide an efficient and cost effective way to diagnose childhood respiratory illnesses across the globe.

Faherty hopes to stop Shigella from wreaking havoc in the digestive system

A research team at Massachusetts General Hospital is hoping to create new treatments for shigellosis, a potentially fatal digestive disorder, by factoring in genetic changes that occur in Shigella bacteria during the journey through the human digestive system.

Dennis Brown, PhD, studies the many impacts of water imbalance in the body

Dr. Brown, Director of the Massachusetts General Hospital Program in Membrane Biology, is looking at the body as a system of water transportation with the goal of generating treatments for life-threatening water balance disorders.

Fatima Cody Stanford, MD, MPH, MPA, addresses barriers and disparities in obesity treatment

Dr. Stanford, an Obesity Medicine Physician at the Massachusetts General Hospital Weight Center, an Associate at the Mass General Disparities Solution Center, and Associated Faculty at the Mass General Mongan Institute for Health Policy, is taking a holistic approach to both treat and advocate for patients who have obesity.

Q&A with Emily Hyle, MD, MSc

Dr. Hyle is an infectious disease clinician investigator at Massachusetts General Hospital, is investigating ways to improve outcomes for patients with HIV and to measure the effectiveness of medical interventions to prevent disease transmission during international travel.

See more investigator profiles


Tsurumi carries on a family tradition of biomedical research

Amy Tsurumi, PhD, a postdoctoral researcher at Massachusetts General Hospital, is investigating new methods to predict vulnerability to infections in burn and trauma patients.

Bouta investigating the role of the lymphatic system in disease

Echoe Bouta, PhD, is working to understand the mechanisms of lipedema, a chronic lymphatic disorder that manifests as increased fat in the lower limbs and causes dramatic, painful swelling.

Parada hopes to make an impact in research and treatment for kidney disease

Xavier Parada, MD, a native of El Salvador, is working on new ways to diagnose and treat chronic kidney disease, a problem of "enormous proportions."

Why does arthritis persist—and sometimes get worse—after a Lyme disease infection?

Robert Lochhead, PhD, is a postdoctoral researcher at Massachusetts General Hospital studying Lyme disease-related arthritis and the relationship between infection and autoimmunity.

See more postdoctoral profiles

Connect with us

Stay up to date on the latest research news by following us on Facebook and Twitter, and be sure to check out the Research Institute blog for original stories, article summaries, tips on communicating science and lots more.


Back to Top